These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 27059924)
1. Interplay between the kinin B1 receptor and inducible nitric oxide synthase in insulin resistance. Haddad Y; Couture R Br J Pharmacol; 2016 Jun; 173(12):1988-2000. PubMed ID: 27059924 [TBL] [Abstract][Full Text] [Related]
2. Suppression of vascular inflammation by kinin B1 receptor antagonism in a rat model of insulin resistance. Dias JP; Couture R J Cardiovasc Pharmacol; 2012 Jul; 60(1):61-9. PubMed ID: 22494994 [TBL] [Abstract][Full Text] [Related]
3. Kininase 1 As a Preclinical Therapeutic Target for Kinin B Haddad Y; Couture R Front Pharmacol; 2017; 8():509. PubMed ID: 28824433 [TBL] [Abstract][Full Text] [Related]
4. High glucose increases B1-kinin receptor expression and signaling in endothelial cells. Rodriguez AI; Pereira-Flores K; Hernández-Salinas R; Boric MP; Velarde V Biochem Biophys Res Commun; 2006 Jun; 345(2):652-9. PubMed ID: 16696940 [TBL] [Abstract][Full Text] [Related]
5. Kinin B1 receptor enhances the oxidative stress in a rat model of insulin resistance: outcome in hypertension, allodynia and metabolic complications. Dias JP; Talbot S; Sénécal J; Carayon P; Couture R PLoS One; 2010 Sep; 5(9):e12622. PubMed ID: 20830306 [TBL] [Abstract][Full Text] [Related]
6. Inducible nitric oxide synthase inhibitor, 1400W, mitigates DFP-induced long-term neurotoxicity in the rat model. Putra M; Sharma S; Gage M; Gasser G; Hinojo-Perez A; Olson A; Gregory-Flores A; Puttachary S; Wang C; Anantharam V; Thippeswamy T Neurobiol Dis; 2020 Jan; 133():104443. PubMed ID: 30940499 [TBL] [Abstract][Full Text] [Related]
7. Differential regulation of inducible and endothelial nitric oxide synthase by kinin B1 and B2 receptors. Kuhr F; Lowry J; Zhang Y; Brovkovych V; Skidgel RA Neuropeptides; 2010 Apr; 44(2):145-54. PubMed ID: 20045558 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of spinal constitutive NOS-2 by 1400W attenuates tissue injury and inflammation-induced hyperalgesia and spinal p38 activation. Tang Q; Svensson CI; Fitzsimmons B; Webb M; Yaksh TL; Hua XY Eur J Neurosci; 2007 May; 25(10):2964-72. PubMed ID: 17561811 [TBL] [Abstract][Full Text] [Related]
9. Blockade of sensory abnormalities and kinin B(1) receptor expression by N-acetyl-L-cysteine and ramipril in a rat model of insulin resistance. Ismael MA; Talbot S; Carbonneau CL; Beauséjour CM; Couture R Eur J Pharmacol; 2008 Jul; 589(1-3):66-72. PubMed ID: 18555989 [TBL] [Abstract][Full Text] [Related]
10. Inducible nitric oxide synthase inhibition by 1400W limits pain hypersensitivity in a neuropathic pain rat model. Staunton CA; Barrett-Jolley R; Djouhri L; Thippeswamy T Exp Physiol; 2018 Apr; 103(4):535-544. PubMed ID: 29441689 [TBL] [Abstract][Full Text] [Related]
11. Blockade of kinin B(1) receptor reverses plasma fatty acids composition changes and body and tissue fat gain in a rat model of insulin resistance. Dias JP; Couture R Diabetes Obes Metab; 2012 Mar; 14(3):244-53. PubMed ID: 22023455 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of iNOS augments cardiovascular action of noradrenaline in streptozotocin-induced diabetes. Cheng X; Cheng XS; Kuo KH; Pang CC Cardiovasc Res; 2004 Nov; 64(2):298-307. PubMed ID: 15485689 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of 1400 W, a novel inhibitor of inducible nitric oxide synthase, in preventing interleukin-1beta-induced suppression of pancreatic islet function in vitro and multiple low-dose streptozotocin-induced diabetes in vivo. Rydgren T; Sandler S Eur J Endocrinol; 2002 Oct; 147(4):543-51. PubMed ID: 12370118 [TBL] [Abstract][Full Text] [Related]
14. Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction. Kato Y; Miura Y; Yamamoto N; Ozaki N; Oiso Y Diabetologia; 2003 Sep; 46(9):1228-33. PubMed ID: 12898012 [TBL] [Abstract][Full Text] [Related]
15. 1400W, a highly selective inducible nitric oxide synthase inhibitor is a potential disease modifier in the rat kainate model of temporal lobe epilepsy. Puttachary S; Sharma S; Verma S; Yang Y; Putra M; Thippeswamy A; Luo D; Thippeswamy T Neurobiol Dis; 2016 Sep; 93():184-200. PubMed ID: 27208748 [TBL] [Abstract][Full Text] [Related]
16. Induction of nitric oxide synthase and over-production of nitric oxide by interleukin-1beta in cultured lacrimal gland acinar cells. Beauregard C; Brandt PC; Chiou GC Exp Eye Res; 2003 Jul; 77(1):109-14. PubMed ID: 12823994 [TBL] [Abstract][Full Text] [Related]
17. Brain kinin B1 receptor is upregulated by the oxidative stress and its activation leads to stereotypic nociceptive behavior in insulin-resistant rats. Dias JP; Gariépy Hde B; Ongali B; Couture R Peptides; 2015 Jul; 69():118-26. PubMed ID: 25959537 [TBL] [Abstract][Full Text] [Related]
18. 1400W, a potent selective inducible NOS inhibitor, improves histopathological outcome following traumatic brain injury in rats. Jafarian-Tehrani M; Louin G; Royo NC; Besson VC; Bohme GA; Plotkine M; Marchand-Verrecchia C Nitric Oxide; 2005 Mar; 12(2):61-9. PubMed ID: 15740979 [TBL] [Abstract][Full Text] [Related]